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A yearlong study was performed to examine the effect of antibiotic administration on the
bacterial gut flora. Gram-negative facultative anaerobic bacteria were recovered from the
feces of healthy adult volunteers administered amoxicillin, minocycline or placebo, and
changes determined in antimicrobial resistance (AMR) gene carriage. Seventy percent
of the 1039 facultative anaerobic isolates recovered were identified by MALDI-TOF as
Escherichia coli. A microarray used to determine virulence and resistance gene carriage
demonstrated that AMR genes were widespread in all administration groups, with the
most common resistance genes being blaTEM, dfr, strB, tet(A), and tet(B). Following
amoxicillin administration, an increase in the proportion of amoxicillin resistant E. coli
and a three-fold increase in the levels of blaTEM gene carriage was observed, an effect
not observed in the other two treatment groups. Detection of virulence genes, including
stx1A, indicated not all E. coli were innocuous commensals. Approximately 150 E. coli
collected from 6 participants were selected for pulse field gel electrophoresis (PFGE), and
a subset used for characterisation of plasmids and Phenotypic Microarrays (PM). PFGE
indicated some E. coli clones had persisted in volunteers for up to 1 year, while others
were transient. Although there were no unique characteristics associated with plasmids
from persistent or transient isolates, PM assays showed transient isolates had greater
adaptability to a range of antiseptic biocides and tetracycline; characteristics which were
lost in some, but not all persistent isolates. This study indicates healthy individuals carry
bacteria harboring resistance to a variety of antibiotics and biocides in their intestinal
tract. Antibiotic administration can have a temporary effect of selecting bacteria, showing
co-resistance to multiple antibiotics, some of which can persist within the gut for up to
1 year.
Keywords: antibiotic trial, resistance genes, facultative anaerobic Gram-negative bacteria, persistent, transient
INTRODUCTION
The use of antibiotics has played a crucial role in the acqui-
sition and proliferation of antimicrobial resistance. A study of
historical plasmids pre and post antibiotic use has demonstrated
that prior to antibiotic utilization many plasmids did not carry
these resistance genes (Hughes and Datta, 1983). However, the
pressure exerted by the use of antibiotics has caused bacteria to
adapt and acquire these elements. Frequently these elements are
acquired from organisms in the environment, which possess them
as a means of protection from natural antibiotics produced by
bacteria inhabiting these niches (Martinez, 2008).
Antimicrobial resistance can be acquired by acquisition of
novel genetic material on mobile elements such as plasmids,
transposons, insertion sequences and, integrons. All play a role in
the spread of resistances seen today. Plasmids have been studied
widely and can carry multiple resistance genes resulting in their
co-selection by several agents. For example, the plasmids encod-
ing blaCTX-M genes frequently encode additional resistance genes
generating multi-drug resistance plasmids, which have become
widespread and problematic. In addition, many plasmids also
carry toxin-antitoxin systems which enable plasmid maintenance
in bacterial cells, in the absence of an antibiotic (Carattoli, 2013).
The commensal bacterial population of the human intestine
is a complex ecosystem. It is thought that the commensal bacte-
rial population can act as a reservoir of antimicrobial resistance
genes that can be disseminated on mobile elements to pathogenic
bacteria and, between bacterial species (Marshall et al., 2009). In
healthy individuals the gut resistome has been shown to carry a
large pool of antibiotic resistance genes (Sommer et al., 2009),
which could act as a reservoir and spread to bacterial pathogens
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that may also be present in the gut. Colonization with resistant
bacteria can occur at an early age during the first weeks after
birth, in the absence of antibiotic use, due to acquisition from
the mother or environment (Zhang et al., 2011). Evidence indi-
cates that the acquisition of resistance genes or the resistome
in an individual can occur without the need for antibiotic use
due to the abundance of mobile elements harboring these genes
(Zhang et al., 2011), and that resistance genes are often main-
tained without the need for selective antibiotic pressure (Salyers
et al., 2004).
In this study we describe the results of a human trial per-
formed to assess the effect of antimicrobial use on facultative
anaerobic Gram-negative bacteria in the gut, bacteria which com-
monly harbor transferable resistance elements. The isolates were
collected as part of the Anitresdev FP7 project (http://www.ucl.
ac.uk/antiresdev). The results from the obligate anaerobic Gram-
negative isolates collected from this study have previously been
reported (Kirchner et al., 2013). A single course of either an
antibiotic (ampicillin or minocycline), or a placebo, was admin-
istered to between 10 and 15 healthy adult participants per group
and they were then sampled periodically over 1 year. Amoxicillin
and Minocycline were chosen as they are frequently prescribed
antimicrobial agents which are of different antibiotic classes. They
also act in different ways with amoxicillin having bactericidal
activity, while minocycline is bacteriostatic. The aim was to deter-
mine if the use of an antibiotic altered the antibiotic resistance
gene carriage in Gram-negative facultative anaerobes present in
the intestinal flora. Unlike many resistome andmicrobiome study
previously published (Moore et al., 2013; Card et al., 2014), we
assessed resistance gene carriage in individual bacteria rather than
in the whole gut bacterial population. This allowed us to deter-
mine the types of bacteria present in the gut that are most likely
to carry resistance genes and is detectable by culture methods
used in this study; to identify the most common resistance deter-
minants they carry, and whether the presence of one resistance
gene may be linked with another. The study also assessed whether
there are differences between Escherichia coli isolated from these
participants at multiple visits (considered persistent), and those
detected at a single visit (considered transient), by using both
molecular profiling and response to stress modulators.
METHODS
CHALLENGE STUDY AND ISOLATE SELECTION
A total of 44 healthy subjects (18–40 years old) were recruited
for this study. The study was conducted in healthy volunteers
from the general public in South West London, UK, between
2010 and 2011. It was designed as an open labeled parallel
group clinical trial. The study was approved by the South West
London Research Ethics Committee (Reference 10/h0806/12)
of St George’s University of London and the Medicines and
Healthcare products Regulatory Agency (2009-017647-34), UK.
The clinical trial was registered in a public registry (study ID
number C09040). Written consent was obtained from all the
volunteers that agreed to participate in this study.
There were 15 subjects allocated to each of the cohorts admin-
istered amoxicillin and minocycline, and 14 subjects in the
placebo cohort. The dosage used was that recommended by the
British National Formulary for amoxicillin 250mg (Amoxil cap-
sules, GlaxoSmithKline, UK), three times daily for 7 days; and
minocycline 100mg (Aknemin capsules, Almirall), twice daily for
5 days. Placebo was given to the control group. Ten subjects with-
drew due to adverse effects and personal reasons; which included
3 from the amoxicillin group, 5 from minocycline group and 2
from the placebo group. Fecal samples were collected from each
volunteer at day 0, before antibiotic administration; at day 11,
immediately after treatment completion; then at 30, 60, 120, 356
days following treatment completion (6 sampling points in total).
Fecal samples obtained from participants from all groups were
serially diluted on to blood agar containing 0.5mg/Lminocycline,
4mg/L minocycline, and 8mg/L amoxicillin to isolate resistant
bacteria, as previously described (Nord et al., 2006). The number
of isolates selected from each participant at each sampling point
was dependant on the number and type of colonies observed
on the 3 plates. After incubation, up to 5 different colony types
were picked from each plate, sub-cultured to purity and stored
at −70◦C for further analysis. Therefore, for each participant up
to 5 colonies or isolates were selected from up to 3 antibiotic
containing plate i.e., up to 15 isolates per sampling point. This
resulted in a total of 1039 facultative anaerobic Gram-negative
isolates being selected across all 6 sampling points from 34
volunteers.
BACTERIAL ISOLATES AND IDENTIFICATION
Purified isolates received at the Animal and Plant Health
Agency (APHA) were cultured on sheep blood agar plates
overnight at 37◦C. The bacterial identity was determined
using Matrix-assisted laser desorption/ionization time- of-flight
(MALDI-TOF) (Carbonnelle et al., 2011).
ANTIMICROBIAL RESISTANCE GENE ARRAY ANALYSIS
A DNA microarray containing probes to 75 resistance genes
encompassing 19 different antimicrobial classes (Batchelor et al.,
2008; Anjum et al., 2011; Card et al., 2013) was used to test all
isolates. For DNA extraction, each strain was grown overnight
on Luria Bertani (LB) agar plates. DNA was extracted by re-
suspending a loopful of fresh growth in 400µl of lysis buffer
(containing 0.24mg/l proteinase K, 0.05% Tween 20, 0.1M
Trizma-HCl), mixed and incubated in a Thermomixer for 2–4 h at
60◦C with agitation at 550 rpm, followed by 95◦C for 15min. Cell
debris was removed following centrifugation and supernatant
used in subsequent steps. The method and primers used for label-
ing of DNA present in the supernatant are as described previously
(Batchelor et al., 2008; Anjum et al., 2011; Card et al., 2013).
Labeled DNA was hybridized to the array using the buffers pro-
vided in the HybPlus Kit (Alere Technologies, Jena, Germany).
For all hybridization and washing steps the arrays were agitated
at 550 rpm in a Thermomixer. Hybridization was performed at
55◦C for 1 h and washing at 30◦C. Horse-radish peroxidase con-
jugated Streptavidin was added for 15min at 30◦C and bound
DNA was detected using Seramun Green (Seramun Diagnostica,
GmbH, Germany). Signals were read using an ArrayMate scanner
and IconoClust software (Alere Technologies). Mean signal inten-
sities of two replicate spots per probe were used for analysis and
values ≥0.5 were considered positive.
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To determine the number of isolates that were multi-drug
resistant (MDR) based on gene carriage, resistance genes were
grouped according to their mode of activity (as classified previ-
ously, Card et al., 2013) and the number of positive groups in each
isolate determined. Integrase genes were not included as they do
not encode for resistance activity. Isolates that were positive for
resistance genes in two or more antibiotic classes were defined
as MDR.
PULSED FIELD GEL ELECTROPHORESIS
Pulsed-field gel electrophoresis (PFGE) using XbaI restriction
endonuclease was performed for selected E. coli isolates accord-
ing to the PulseNet protocol for E. coli O157 (Centers for
Disease Control and Prevention, Atlanta, USA; http://www.
cdc.gov/pulsenet/pathogens/index.html). Clustering analysis was
performed using BioNumerics (Applied Math). Dendrograms
were generated using Gel Compare and banding patterns ana-
lyzed using DICE co-efficient and unweighted pair group method
with arithmetic averages (UPGMA).
PLASMID ANALYSIS AND TRANSFERABILITY STUDIES
Plasmid DNA was extracted using a method described previ-
ously (Kado and Liu, 1981; Liebana et al., 2004). Plasmids were
analyzed using BioNumerics to estimate their size; E. coli strain
39R861 containing plasmids of known sizes (148, 63.4, 36, and
6.9 kb) and a supercoiled DNA Ladder (Sigma-Aldrich, UK), were
used for comparison.
To identify the addiction systems, which are a toxin-antitoxin
system carried by plasmids for maintenance in bacteria, a PCR
method described previously was used (Mnif et al., 2010). Seven
PCRs were used to detect, pemk, hok-sok, ccdAB, relBE, vagCD,
pndAC, and srnBC. A PCR based method was also used to deter-
mine the incompatibility groups of the plasmids carried by these
isolates. Amultiplex PCR kit fromDiatheva (Fano, Italy), which is
based on a previous publication (Carattoli et al., 2005), was used.
The kit was used according to the manufacturer’s instructions.
An in-broth conjugation method was used to isolate conjuga-
tive plasmids carried by these E. coli. Salmonella Typhimurium
strain 26R775 was used as the recipient for these studies. Each
strain was grown overnight at 37◦C in static conditions in 3ml
LB broth. Conjugal-transfer was assessed after 5 and 24 h incu-
bation by plating on Rambach containing 100mg/l rifampicin,
and either 16mg/l ampicillin, 15mg/l tetracycline, or 8mg/l
streptomycin, depending on the resistance genes carried by the
parent strain. Following overnight incubation at 37◦C, plates were
enumerated and, conjugation rates determined where transfer
occurred.
MULTI-LOCUS SEQUENCE TYPING (MLST)
A subset of 14 E. coli selected from PFGE, were analyzed by multi-
locus sequencing typing (MLST). This was performed using the
loci, adk, fumC, gyrB, icd,mdh, purA, and recA, according to pub-
lished method (Wirth et al., 2006). Sequences were compared to
the E. coli MLST database held at the University of Cork, Dublin
(http://mlst.warwick.ac.uk/mlst/dbs/Ecoli/).
ASSESSMENT OF STRESS RESPONSE MECHANISMS
For assessment of stress response, isolates were analyzed using the
Biolog phenotype microarray (PM) system (Hayward, CA, USA),
which enables a high throughput screen of bacterial response
to metabolic effector compounds (Bochner et al., 2001). Each
isolate was analyzed using 10 PM plates containing antimicro-
bials (PM11–14) and other metabolic effectors (PM15–20). All
media, reagents, and PM panels were used according to manufac-
turer’s instructions. Bacterial isolates to be tested were cultured
for 16 h on LB agar plates at 37◦C in aerobic conditions. Cells
were re-suspended in 10ml of inoculating fluid (IF-0a) and the
optical density adjusted to 85% transmittance. For each plate
12ml of media IF-10a was mixed with 120µl of bacterial cell sus-
pension; this was also supplemented with a final concentration
of 0.02M sodium succinate/0.002mM ferric citrate. Tetrazolium
dye A, supplied by Biolog Inc (Hayward, CA, USA), was used
to measure the cellular respiration. All microplates were incu-
bated in the Omnilog instrument at 37◦C andmonitored for color
change at 15min intervals for 120 h. Kinetic data was analyzed
with OmniLog-PM software (Biolog). All experiments were per-
formed in duplicate on different days and comparisons between
strains were based on the average of the area under the curve
(AUC) values at 24 h. A comparison of respiratory profiles was
performed by hierarchical clustering and PCA analysis with AUC
values using the program R (www.bioconductor.org/).
RESULTS
ALTERATIONS IN GENE CARRIAGE IN THE BACTERIAL POPULATION
FOLLOWING ANTIBIOTIC ADMINISTRATION
Isolate characterization and resistance gene carriage
This work reports on Gram-negative fecal isolates that were
collected over one year from 3 groups, at six different time
points. The 3 groups included in the study were: amoxicillin
administered; minocycline administered and placebo. All isolates
grew under aerobic conditions, were Gram-negative bacteria, and
belonged to 19 bacterial genera (Supplementary Table 1). Isolates
were picked depending on their colony morphology after growth
on selective media containing antibiotic; the total number of iso-
lates collected at each sampling point from each participant varied
from 0 to 15 and the total number isolated across all 3 groups
and 6 sampling points, were 1039. There were 378 isolates from
the amoxicillin administered group (133 from amoxicillin plates,
241 fromminocycline plates, 4 were unknown), 248 isolates from
the minocycline administered group (83 from amoxicillin plates,
162 from minocycline plates, 3 were unknown), and 413 iso-
lates from the placebo (151 from amoxicillin plates, 256 from
minocycline plates, 6 were unknown). Seventy percent of those
tested were E. coli (n = 729), with the other major groups being
Klebsiella spp. (8.8%), Citrobacter spp. (9.1%) and Enterobacter
spp. (7.9%).
The carriage of antimicrobial resistance genes was assessed
using a DNA microarray previously developed and updated by
our group (Batchelor et al., 2008; Anjum et al., 2011; Card et al.,
2013). E. coliwere positive for up to 15 genes detected by the array,
while among the non-E. coli this comprised up to 12 genes, with
the largest number of genes detected in Citrobacter spp. Sixty per-
cent of the isolates tested were positive for at least one AMR gene
present on the array. Those harboring no detectable resistance
genes by array included 305 isolates present on minocycline con-
taining plates, collected from all groups and 109 isolates present
on amoxicillin containing, plates collected from all groups.
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FIGURE 1 | The percentage of isolates carrying the most common
antibiotic resistance associated genes detected during the study. A
total of 1039 isolates were tested, 413 of these isolates were collected
from volunteers given a placebo, 378 from those given amoxicillin and 248
from those given minocycline.
The most frequently detected genes in all species are shown
in Figure 1. All these genes were more frequently associated with
E. coli. The exception to this was the gene encoding the AmpC-
type enzyme CMY, which was detected in 64% of the Citrobacter
spp. (C. freundii, C. braakii, C. youngae, and C. koseri). Overall
i.e., from all time points in the study, 36.9% of all isolates had a
MDR genotype (seeMethods for definition); while approximately
50% of all the E. coli tested had an MDR genotype.
Effect of antibiotic administration on resistance gene carriage
In the minocycline group 36.7% of the total isolates recovered,
from all time points in this group, carried genes for two or more
antibiotic classes. In the amoxicillin and placebo groups this was,
35.5 and 38.5%, respectively. To assess any effect of antibiotic
administration, we determined the change over time in the pro-
portion of isolates with MDR genotype. In the amoxicillin group
the proportion of isolates with MDR genotype increased between
days 0 and 11 from 22 to 49% (Figure 2), which matched the phe-
notypic results obtained using a panel of 22 antimicrobial agents
or combinations using the VITEK system (data not shown). In the
minocycline administration group the proportion of isolates with
a MDR genotype did not change between day 0 and 11 (36 and
38%, respectively; Figure 2) and in the placebo group, the pro-
portion of isolates with an MDR genotype was on average 38.5%,
for the entire study (range 29–54%); both matched the respective
phenotypic data (data not shown). The wide range in the placebo
was the effect of an increase in MDR isolates at 120 days to 54%
from between 30 and 40% in first four and last sampling point;
the cause of this increase was unknown.
The increase in the resistance genotype observed in the amox-
icillin group was due to an overall increase in the percentage of
blaTEM positive E. coli present in this group from day 0 (13.9%)
to day 11 (48.3%), which was sustained for up to 30 days fol-
lowing amoxicillin administration (Figure 3); after this period
there was a fall in the level of TEM positive isolates although it
FIGURE 2 | The proportion of genotypically multi-resistant (i.e.,
carrying genes for 2 or more resistance gene class) isolate in each
treatment group during the study.
FIGURE 3 | The percentage of blaTEM positive E. coli collected from
amoxicillin and placebo treatment groups.
did not return to pre-administration levels. However, only half
the participants challenged with amoxicillin accounted for this
increase, indicating person to person variation (data not shown).
An increase in the proportion of tet(B) positive E. coli (from
8.3 to 20%) was also observed immediately following amoxicillin
administration. At 30 days post-administration, the levels of strB,
sul1, intI1, dfr, and tet(A) increased above pre-administration
levels; this was probably not a direct effect of ampicillin admin-
istration (data not shown). In the placebo group the proportion
of blaTEM positive E. coli remained between 33 and 40% for the
entire study. In theminocycline administration group the propor-
tion of blaTEM positive E. coli decreased from 40 to 22% between
day 0 and 11. However, the change was probably due to the small
number of blaTEM positive isolates present in this group and not
an effect of treatment (data not shown).
Virulence genes present
The DNA array used in the study also encodes genes associated
with E. coli virulence (Anjum et al., 2007). Virulence associated
genes were detected in 57.7% of the isolates tested in this study,
including some non-E. coli species. The most commonly detected
genes were: senB (25.1% of all isolates tested); iss (34.1%); prfB
(20.9%); iroN (11.8%); cdtB (10.9%); and mchB, mchC, and
mchF, which were present in 10.7, 10, and 13.4% of total isolates,
respectively. Also of interest was the detection of two Shiga-toxin
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(stx1A) positive E. coli from one participant; the presence of this
gene was confirmed by PCR (data not shown).
CHARACTERIZATION OF TRANSIENT AND PERSISTENT ISOLATES
Selection of isolates and PFGE analysis
During our study we noted in all three groups the presence of
E. coli isolates with similar or identical AMR gene profiles from
different time points. To determine if these isolates represented
the same clones, we selected (based on numbers of E. coli recov-
ered and their resistance profile), two participants from each
administration group. A total of 150 E. coli were collected from
these participants, and all were analyzed by PFGE. Isolates which
were collected from different sampling points, but showed indis-
tinguishable PFGE profiles (i.e., clustered together with >85%
similarity using UPGMA analysis) were termed “persistent,” and,
those isolates with varied PFGE profiles (i.e., from different time
points and did not cluster together by UPMGA analysis; they
showed<85% similarity) were termed “transient.”
Forty E. coli isolates from the amoxicillin administration group
from participants A and Bwere analyzed by PFGE. Nine persistent
E. coli with indistinguishable profiles were recovered from A from
all six sampling points, between day 0 and day 365, while a clus-
ter of 8 isolates with identical PFGE profiles were collected from
B from two sampling points, days 30 and 60, following antibiotic
administration. Twenty-three i.e., 57.5% isolates from A and B
had unique PFGE profiles, they were considered transient. Fifty-
eight E. coli from the minocycline challenged participants, C and
D, were analyzed by PFGE. Four persistent clusters with indistin-
guishable PFGE profiles were identified (2 from each participant).
Each persistent cluster was represented by between 6 and 11 iso-
lates. The clusters from participant C were detected from four
sampling points, day 0 up to day 120, and the two clusters from
participant D persisted at two different sampling points, from day
0 to 11, and from day 30 to 120, respectively. Twenty-five isolates
i.e., 43.1% of isolates tested from C and D had unique PFGE, and
were considered transient. Fifty E. coli from placebo participants
E and F were analyzed by PFGE. A single cluster of 9 isolates
was identified in participant F, which persisted over four sam-
pling points between day 0 and day 120. In participant F, three
additional clusters (7 isolates in total) were detected across two
visits each. There were no persistent isolates identified from par-
ticipant E. Thirty-four i.e., 68% of the placebo isolates tested were
considered transient.
Plasmid characterisation and MLST
Fourteen of the 150 E. coli representing 7 transient and 7 dif-
ferent persistent clones (as identified by PFGE) were selected
for further analysis. At least 2 persistent and 2 transient isolates
were selected from each group (Table 1) for plasmid charac-
terization. The aim was to investigate, whether there were any
contributions from resident plasmids and antibiotic administra-
tion, which impelled isolates to being transient or persistent.
Plasmid profiling determined that the isolates carried up to 6
plasmids ranging in size between 4 and 160 kb; up to 5 repli-
con types; and between 1 and 5 addiction systems (Table 1).
Six isolates contained plasmids which were transferable by con-
jugation and belonged to a range of incompatibility groups.
Conjugative plasmids encoding ampicillin resistance were all pos-
itive for blaTEM, and also carried genes encoding resistance to
tetracycline, aminoglycoside, sulphonamide, and trimethoprim
(Table 1). However, these molecular approaches did not identify
any plasmid associated trait specific to the transient or persistent
group, or antibiotic administration.
The MLST types were determined for the 14 selected isolates.
Six of the 14 isolates belonged to ST complex 10; the remain-
ing isolates belonged to a variety of ST (Table 1). A specific ST
complex was not associated with transient or persistent group, or
antibiotic administration.
Phenotypic microarrays
Biolog phenotypemicroarrays were utilized to determine whether
there were conditions which could help explain why some iso-
lates were transient and others persistent, and if there was an
effect of antibiotic administration. The 14 isolates selected above
were exposed to different stress modulators and their ability to
respire in the conditions measured (Supplementary Table 2). A
hierarchical clustering was performed on the results of respiration
(AUC values) of isolates using compounds present on all 10 plates
(Figure 4). In general, technical replicates showed high similarity,
but it was not possible to distinguish between isolates from the
minocycline, amoxicillin, and placebo groups using this pheno-
typic method. However two groups of isolates were detected by
hierarchical clustering; group 1 contained 4 isolates and group 2
contained 10 isolates. All seven transient isolates grouped within
group 2, while persistent isolates were divided between groups 1
and 2 (Figure 4). A principal component analysis (PCA) was also
performed on the results of respiration (AUC values) and identi-
fied the same two groups shown in Figure 4 (data not shown).
Isolates in each group did not represent any single ST type or
complex. Several compounds were identified in which all or most
isolates within group 2 were able to respire (Table 2). These
included several antiseptic biocidal agents such as domiphen bro-
mide and alexidine, and two compounds which are known to
modulate efflux mechanisms, chlorpromazine and promethazine
(Table 2). Surprisingly, all isolates from group 2 showed the pres-
ence of tetracycline resistance genes by array (Table 1), which
were absent from all group 1 isolates; as a result differential res-
piration rates were observed between group 1 and group 2 for
several tetracycline derivatives (Table 2).
DISCUSSION
Here we describe the results of a yearlong study in which healthy
individuals were given a course of antibiotics, and an analysis
performed on the Gram-negative fecal facultative anaerobic bac-
teria collected during the study. Although 18 genera of bacteria
were detected, the predominant bacterial species detected in the
facultative anaerobic gut flora was E. coli; Klebsiella, Citrobacter,
and Enterobacter were also prevalent. It is known that the fac-
ultative anaerobic flora is the subdominant population in the
gut with the dominant population consisting mainly of members
of the Firmicutes and Bacteroidetes phyla (Eckburg et al., 2005).
Nevertheless, the gastrointestinal tract can contain between 102
and 1010 Enterobacteria, with the highest proportion being in the
feces (Simon and Gorbach, 1984).
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FIGURE 4 | Dendrogram showing the Biolog results for 14 selected
isolates representing transient and persistent isolates. Each experiment
was repeated in duplicate and both replicates are represented individually
in the figure. The two groups generated by comparing the respiration
profiles of the isolates are indicated. The Hierarchical clustering was used
to generate a dendrogram using R-conductor program (www.bioconductor.
org/). The sample ID is defined as such: first T or P indicating if a strain is
transient or persistent, the second letter (A, M, P) indicates which
treatment was administered and the final ARD reference is the isolate
number.
Table 2 | Compounds identified using the Biolog for which differential
respiration levels were detected between groups 1 and 2.
Compound AUC values Adjusted
P-value
Group 1 Group 2
Tetracycline derivatives
(e.g., Doxycycline)
11.74 14.61 0
Chlorpromazine 11.82 13.42 0
Promethazine 11.90 13.65 0.003
Alexidine 12.40 14.15 0.015
Domiphen bromide 11.40 13.30 0.023
Identification of trends in the results was difficult as the base-
line level of resistance genes, i.e. resistance at time point zero, was
high in all groups including the placebo. On average, 58% of all
isolates tested carried at least one resistance gene (detectable by
array) prior to treatment (62% minocycline, 50.7% amoxicillin,
61% placebo) and in the placebo group some isolates carried up
to 11 resistance genes at the start of the study. This demonstrated
that generally the levels of resistance gene carriage in the gut flora
were high in the healthy adults randomly selected for this study;
we were unable to detect the cause for this. However, it is note-
worthy that for some participants we did not detect any resistance
genes throughout the study, while for other participants the num-
ber of resistance genes fluctuated during the study; although this
was irrespective of antibiotic administration it was particularly
apparent in the placebo group (data not shown).
Nevertheless, it was clear from our results that following the
administration of amoxicillin the levels of blaTEM gene positive
E. coli isolates (blaTEM gene confers resistance to amoxicillin)
increased, suggesting this antibiotic was selecting for these iso-
lates; the levels remained above the pre-challenge levels through-
out the remainder of the study. A small increase in tetracycline
resistance genes was also noted post-amoxicillin administration,
linked to the increase in resistant E. coli, indicating co-selection. A
similar increase was not seen in the other treatment or the placebo
group for any facultative anaerobic bacteria. Also, amoxicillin use
did not have the same effect on any of the other beta-lactamase
resistance genes detectable by the array. The increase in blaTEM
positive E. coli isolates following amoxicillin use could be due to
the transfer of blaTEM to sensitive E. coli and/or the proliferation
of blaTEM E. coli isolates as they are better able to survive. The
high percentage similarity in E. coli from the PFGE data, from
two participants in the amoxicillin group, supports proliferation
of blaTEM positive E. coli (data not shown). However, the conju-
gation experiments demonstrated that blaTEM was contained on
transferable plasmids, which harbor other resistances including
tetracycline (Table 1). Therefore, the increase seen post amoxi-
cillin use could reflect spread of a multi-resistant plasmid in some
participants and proliferation of a multi-resistant E. coli in others.
The potential of plasmids to spread between bacteria in the gut is
already known and has been demonstrated using Salmonella and
E. coli in a gut mouse model (Stecher et al., 2012).
Extended spectrum beta-lactamase resistance was rare in this
study, with only 3.7 and 2.9% of all isolates tested demonstrat-
ing resistance to cefotaxime or ceftazidime, respectively. The
blaCTX-M genes were present in only 20 of the E. coli tested, which
were from two participants and carried either blaCTX-M-14 or
blaCTX-M-15. Sommer et al. (2009) have also demonstrated the
presence of blaCTX-M during analysis of the resistome in healthy
volunteers (Sommer et al., 2009). It is known that blaTEM can
be prevalent among E. coli and can have a wide-spectrum of
beta-lactamase activity whenmutations are introduced (Bush and
Jacoby, 2010), but within this study we did not determine the
spectrum of activity for the TEM enzymes.
Analysis of the virulence genes carried by the E. coli iso-
lates demonstrated that although these E. coli are thought to be
“commensals” isolated from healthy individuals, several harbored
genes with distinct virulence characteristics associated with dif-
ferent E. coli pathotypes. For example, the presence of the iss
gene has been associated with extra-intestinal pathogenic E. coli
and encodes a protein involved in serum survival (Johnson et al.,
2008); while senB is a plasmid encoded enterotoxin gene asso-
ciated with Entero-invasive E. coli (Nataro et al., 1995). Genes
associated with Entero-pathogenic, Entero-toxigenic, and Entero-
aggregative E. coli were also detected during this study (Anjum
et al., 2007). In addition, two Shiga-toxin positive E. coli (STEC)
isolates were detected from an apparently healthy participant.
Both STEC strains carried stx1 and lacked the eae gene which
encodes an adhesion protein involved in enterocyte attachment;
characteristics that have been associated with less virulent STEC
(Beutin et al., 2004), which are less likely to elicit the severe symp-
toms seen in infections associated with highly pathogenic E. coli
O157 (Friedrich et al., 2002; Anjum et al., 2007, 2014).
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Comparison of the E. coli PFGE profiles demonstrated that
isolates with identical PFGE profiles were detected at several sam-
pling points demonstrating the persistence of the same clone; in
some instances these clones were detected for the entire study.
In this study bacteria were selected based on colony morphol-
ogy following their initial selection on antibiotic plates, therefore
the isolates selected are likely to represent a snapshot of the
most prevalent population/clone at the time of the sampling.
Conversely, those isolates that showed unique PFGE profiles (i.e.,
transient) and were detected at one sampling point, were unable
to persist, or at least were not the most prevalent clone at other
sampling points and hence remained undetected. A larger sample
size or more frequent sampling may have increased the proba-
bility of detecting transient isolates that maybe present. In many
instances multiple colonies from the same sampling point showed
the same AMR and PFGE profiles, indicating the same clones had
been selected on multiple occasions.
Following the identification of persistent and transient E. coli
isolates, it was of interest to know whether there were any plasmid
characteristics that distinguished these groups, enabling estab-
lishment of the former in the human gut, over the latter. Plasmid
analysis, using methods employed in this study, demonstrated
that there were no unique characteristics that could be used to dis-
tinguish between plasmids from isolates considered persistent and
transient. However, the most common MLST complex detected,
including both persistent and transient isolates was ST complex
10, which has been reported throughout the world in humans and
animals (http://mlst.ucc.ie/mlst/dbs/Ecoli/).
The PM Biolog system was used to assess differences in bacte-
rial fitness/survival in the presence of different stress modulators,
including sub lethal doses of antibiotics, in selected persistent and
transient isolates from the 3 different treatment groups. Although
it was not possible to distinguish between isolates from the 3
groups with this method, we were able to distinguish between
some isolates that persisted in the gut and those that appeared
transient. All transient isolates selected were better able to metab-
olize several antiseptic biocidal compounds, which could help in
their ability to survive in different conditions. These isolates were
also all resistant to tetracycline. Ciric et al. (2011) have reported
the presence of a Tn916-like element from Streptococcus oralis
isolated from a human oral cavity to harbor both a tetracycline
resistance gene and an antiseptic resistance protein. Therefore,
the tetracycline and biocidal resistant genes may be present on
a mobile element in all transient and some persistent isolates. But
several persistent E. coli isolates had possibly lost this mobile ele-
ment as they adapted to a stable gut environment, and thereby,
lost the ability to metabolize the biocidal compounds.
It is worth noting that 20% of the 1039 isolates examined
were not fully resistant to the antibiotics used for their selection,
the majority being from minocycline selection plates. This is
probably because these isolates were not clinically resistant. There
is no clinical breakpoint set by EUCAST for minocycline in
Enterobacteriaceae, although historically BSAC have suggested 0.5
mg/L andCSLI 4 or 8mg/L (http://www.eucast.org/fileadmin/src/
media/PDFs/EUCAST_files/Rationale_documents/Minocycline_
Rationale_Document_1.0_20091202.pdf). The epidemiological
cut-off (ECOFF) for minocycline differs depending on species
and is in the range of 0.25mg/L to 64mg/L. For E. coli the ECOFF
is 4mg/L, and 8mg/L for Klebsiella spp. and Citrobacter spp.,
and the selection plates contained either 0.5mg/L minocycline
or 4mg/L minocycline. Also, many non-E. coli isolates, which
were recovered on the amoxicillin plates, harbored no detectable
resistance genes by array. It is likely that for some of the non-
E. coli recovered the genes responsible for resistance in these
species were not represented on the array, or they may have been
intrinsically resistant to the selective agent, or they were protected
by growing adjacent to a resistant organism.
In conclusion, this study has highlighted that there is a diverse
range of resistance genes circulating in the gut of healthy individ-
uals in the absence of selective pressures, including those such as
blaCTX-M, which are of clinical concern. We showed that the use
of antibiotics can have a temporary effect on the resistance genes
present. In addition, the detection of virulence genes in E. coli
indicates that not all E. coli present in the human gut are innocu-
ous commensals, and it is common for E. coli to persist in the gut
for different time periods, which may result in loss of genes and
adaptation to the gut environment.
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